Our findings suggested that RNF182 exerts a tumor suppressor effect in NSCLC through inhibiting cell growth and promoting cell cycle arrest that are key characteristics of cancer progression (30). This evidence concerns the gene RNF182 and non-small cell lung carcinoma.